Skip to content

Prophylaxis guided by CD4 cell count a 'beacon of hope' for patients in poorer countries with no access to HIV treatment

WHO issues guidelines on use of cotrimoxazole prophylaxis

Cotrimoxazole prophylaxis is feasible and effective in HIV-1 infected adult Ugandans but resistance concerns persist

Co-trimoxazole prophylaxis is highly effective against malaria

Immune Reconstitution Inflammatory Syndrome (IRIS) observed in almost a third of advanced patients beginning antiretroviral therapy in Texan study

Cotrimoxazole prophylaxis reduces the risk of death in TB patients

Co-trimoxazole affects survival, CD4 counts, viral load, in HIV-positive Ugandans

TB rates and mortality similar in HIV-1 and HIV-2 infected patients